000 | 01963 a2200529 4500 | ||
---|---|---|---|
005 | 20250516223630.0 | ||
264 | 0 | _c20150619 | |
008 | 201506s 0 0 eng d | ||
022 | _a1098-1136 | ||
024 | 7 |
_a10.1002/glia.22724 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Qingshan | |
245 | 0 | 0 |
_aSubpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases. _h[electronic resource] |
260 |
_bGlia _cDec 2014 |
||
300 |
_a2034-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium-Binding Proteins _xmetabolism |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 |
_aElectron Transport Complex I _xmetabolism |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
650 | 0 | 4 |
_aMesencephalon _xcytology |
650 | 0 | 4 |
_aMicrofilament Proteins _xmetabolism |
650 | 0 | 4 |
_aMicroglia _xdrug effects |
650 | 0 | 4 |
_aNADPH Oxidases _xmetabolism |
650 | 0 | 4 |
_aNADPH-Ferrihemoprotein Reductase _xmetabolism |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xmetabolism |
650 | 0 | 4 |
_aNitrites _xmetabolism |
650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
650 | 0 | 4 |
_aSuperoxides _xmetabolism |
650 | 0 | 4 |
_aThioredoxin-Disulfide Reductase _xmetabolism |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
650 | 0 | 4 |
_aXanthine Oxidase _xmetabolism |
700 | 1 | _aChu, Chun-Hsien | |
700 | 1 | _aOyarzabal, Esteban | |
700 | 1 | _aJiang, Lulu | |
700 | 1 | _aChen, Shih-Heng | |
700 | 1 | _aWilson, Belinda | |
700 | 1 | _aQian, Li | |
700 | 1 | _aHong, Jau-Shyong | |
773 | 0 |
_tGlia _gvol. 62 _gno. 12 _gp. 2034-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/glia.22724 _zAvailable from publisher's website |
999 |
_c24025004 _d24025004 |